Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...

The news eases some of the pressure on Pfizer Chief Executive Officer Albert Bourla, who has insisted ... have fallen by more than 50% since 2021, as demand for its Covid medicines dried up ...

Investors have been cool to Pfizer, with shares down some 50% since record highs in 2021. Pfizer Chief Executive Albert Bourla has been looking to turn around the company's performance, taking steps ...

Pfizer CEO Albert Bourla highlighted the risks and opportunities of radical ... Vaccine hesitancy isn’t new, but the scale of resistance we’re witnessing today is unprecedented. A 2021 study published ...

Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to ...

and remain down more than 50% since hitting an all-time high around $61 in December 2021. Pfizer’s stock is also still trading below where it was when current CEO Albert Bourla took over.